Published in Proc Natl Acad Sci U S A on March 08, 2007
Oligodendrocytes: biology and pathology. Acta Neuropathol (2009) 1.81
Epidermal growth factor induces the progeny of subventricular zone type B cells to migrate and differentiate into oligodendrocytes. Stem Cells (2009) 1.71
Activated T-cells inhibit neurogenesis by releasing granzyme B: rescue by Kv1.3 blockers. J Neurosci (2010) 1.69
Persistent inflammation alters the function of the endogenous brain stem cell compartment. Brain (2008) 1.67
Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosis. J Transl Med (2009) 1.62
Cell migration in the normal and pathological postnatal mammalian brain. Prog Neurobiol (2009) 1.56
Inhibition of Gli1 mobilizes endogenous neural stem cells for remyelination. Nature (2015) 1.49
Brain regeneration in physiology and pathology: the immune signature driving therapeutic plasticity of neural stem cells. Physiol Rev (2011) 1.40
Oligodendrocyte development and the onset of myelination in the human fetal brain. Front Neuroanat (2009) 1.29
Oligodendrogenesis in the subventricular zone and the role of epidermal growth factor. Brain Res Rev (2011) 1.28
Reduced EGFR signaling in progenitor cells of the adult subventricular zone attenuates oligodendrogenesis after demyelination. Neuron Glia Biol (2007) 1.17
Reversible neural stem cell niche dysfunction in a model of multiple sclerosis. Ann Neurol (2011) 1.12
Glial development: the crossroads of regeneration and repair in the CNS. Neuron (2014) 1.12
Integrin/Chemokine receptor interactions in the pathogenesis of experimental autoimmune encephalomyelitis. J Neuroimmune Pharmacol (2014) 1.10
Paradoxical dysregulation of the neural stem cell pathway sonic hedgehog-Gli1 in autoimmune encephalomyelitis and multiple sclerosis. Ann Neurol (2008) 1.08
Oligodendrogenesis after cerebral ischemia. Front Cell Neurosci (2013) 1.06
Inflammation-induced subventricular zone dysfunction leads to olfactory deficits in a targeted mouse model of multiple sclerosis. J Clin Invest (2011) 1.03
Relapsing-remitting central nervous system autoimmunity mediated by GFAP-specific CD8 T cells. J Immunol (2014) 1.01
The role of CXCR4 signaling in the migration of transplanted oligodendrocyte progenitors into the cerebral white matter. Neurobiol Dis (2011) 1.00
Chemokine CXCL12 in neurodegenerative diseases: an SOS signal for stem cell-based repair. Trends Neurosci (2012) 0.99
Sox10 directs neural stem cells toward the oligodendrocyte lineage by decreasing Suppressor of Fused expression. Proc Natl Acad Sci U S A (2010) 0.98
From fish to man: understanding endogenous remyelination in central nervous system demyelinating diseases. Brain (2008) 0.96
Inhibition of p53 transcriptional activity: a potential target for future development of therapeutic strategies for primary demyelination. J Neurosci (2008) 0.95
Mechanisms of oligodendrocyte regeneration from ventricular-subventricular zone-derived progenitor cells in white matter diseases. Front Cell Neurosci (2013) 0.94
Adult CST-null mice maintain an increased number of oligodendrocytes. J Neurosci Res (2009) 0.94
Concise review: Quiescent and active states of endogenous adult neural stem cells: identification and characterization. Stem Cells (2011) 0.93
Ascl1/Mash1 promotes brain oligodendrogenesis during myelination and remyelination. J Neurosci (2013) 0.92
Enhancement of ventricular-subventricular zone-derived neurogenesis and oligodendrogenesis by erythropoietin and its derivatives. Front Cell Neurosci (2013) 0.91
Neural stem cell niches in health and diseases. Curr Pharm Des (2012) 0.91
Remyelination after chronic spinal cord injury is associated with proliferation of endogenous adult progenitor cells after systemic administration of guanosine. Purinergic Signal (2008) 0.91
Cdk2 loss accelerates precursor differentiation and remyelination in the adult central nervous system. J Cell Biol (2011) 0.91
Microglia-induced IL-6 protects against neuronal loss following HSV-1 infection of neural progenitor cells. Glia (2014) 0.91
Myelin repair strategies: a cellular view. Curr Opin Neurol (2008) 0.89
Reelin controls progenitor cell migration in the healthy and pathological adult mouse brain. PLoS One (2011) 0.88
Oligodendrogenesis in the normal and pathological central nervous system. Front Neurosci (2014) 0.87
1,25-Dihydroxyvitamin D3 enhances neural stem cell proliferation and oligodendrocyte differentiation. Exp Mol Pathol (2015) 0.87
Gain of Olig2 function in oligodendrocyte progenitors promotes remyelination. Brain (2015) 0.85
Proliferation but not migration is associated with blood vessels during development of the rostral migratory stream. Dev Neurosci (2010) 0.83
G-protein-coupled receptors in adult neurogenesis. Pharmacol Rev (2012) 0.83
Oligodendrocyte lineage and subventricular zone response to traumatic axonal injury in the corpus callosum. J Neuropathol Exp Neurol (2013) 0.83
The subventricular zone is able to respond to a demyelinating lesion after localized radiation. Stem Cells (2014) 0.83
Feasibility of cell therapy in multiple sclerosis: a systematic review of 83 studies. Int J Hematol Oncol Stem Cell Res (2013) 0.83
Increased precursor cell proliferation after deep brain stimulation for Parkinson's disease: a human study. PLoS One (2014) 0.83
Growth factor regulation of remyelination: behind the growing interest in endogenous cell repair of the CNS. Future Neurol (2007) 0.82
Beta4 tubulin identifies a primitive cell source for oligodendrocytes in the mammalian brain. J Neurosci (2009) 0.82
Signalling pathways that inhibit the capacity of precursor cells for myelin repair. Int J Mol Sci (2013) 0.81
Myelin recovery in multiple sclerosis: the challenge of remyelination. Brain Sci (2013) 0.81
Hematopoietic cell activation in the subventricular zone after Theiler's virus infection. J Neuroinflammation (2008) 0.80
ApoTransferrin: dual role on adult subventricular zone-derived neurospheres. PLoS One (2012) 0.79
N-cadherin promotes recruitment and migration of neural progenitor cells from the SVZ neural stem cell niche into demyelinated lesions. J Neurosci (2014) 0.79
Loss of galectin-3 decreases the number of immune cells in the subventricular zone and restores proliferation in a viral model of multiple sclerosis. Glia (2015) 0.79
Anti-inflammatory treatment induced regenerative oligodendrogenesis in parkinsonian mice. Stem Cell Res Ther (2012) 0.78
Region and dynamic specificities of adult neural stem cells and oligodendrocyte precursors in myelin regeneration in the mouse brain. Biol Open (2015) 0.78
Pattern of CXCR7 Gene Expression in Mouse Brain Under Normal and Inflammatory Conditions. J Neuroimmune Pharmacol (2015) 0.78
The neuroprotective effect exerted by oligodendroglial progenitors on ischemically impaired hippocampal cells. Mol Neurobiol (2013) 0.78
Neural and oligodendrocyte progenitor cells: transferrin effects on cell proliferation. ASN Neuro (2013) 0.78
Targeting oligodendrocyte protection and remyelination in multiple sclerosis. Mt Sinai J Med (2011) 0.78
Activation of endogenous neural stem cells for multiple sclerosis therapy. Front Neurosci (2015) 0.77
Stem cells in the nervous system. Am J Phys Med Rehabil (2014) 0.77
Promoting myelin repair and return of function in multiple sclerosis. FEBS Lett (2011) 0.77
Role of T cell-glial cell interactions in creating and amplifying central nervous system inflammation and multiple sclerosis disease symptoms. Front Cell Neurosci (2015) 0.77
Differential requirement of cyclin-dependent kinase 2 for oligodendrocyte progenitor cell proliferation and differentiation. Cell Div (2012) 0.77
Demyelination-Induced Inflammation Attracts Newly Born Neurons to the White Matter. Mol Neurobiol (2016) 0.76
Contribution of the oligodendrocyte lineage to CNS repair and neurodegenerative pathologies. Neuropharmacology (2016) 0.76
Interferon Gamma: Influence on Neural Stem Cell Function in Neurodegenerative and Neuroinflammatory Disease. Clin Med Insights Pathol (2016) 0.76
Heterogeneity in oligodendroglia: Is it relevant to mouse models and human disease? J Neurosci Res (2016) 0.76
Taking Advantage of Nature's Gift: Can Endogenous Neural Stem Cells Improve Myelin Regeneration? Int J Mol Sci (2016) 0.76
Mosaic Subventricular Origins of Forebrain Oligodendrogenesis. Front Neurosci (2016) 0.76
Subependymal Zone-Derived Oligodendroblasts Respond to Focal Demyelination but Fail to Generate Myelin in Young and Aged Mice. Stem Cell Reports (2017) 0.75
Promoting in vivo remyelination with small molecules: a neuroreparative pharmacological treatment for Multiple Sclerosis. Sci Rep (2017) 0.75
The Neurofilament-Derived Peptide NFL-TBS.40-63 Targets Neural Stem Cells and Affects Their Properties. Stem Cells Transl Med (2016) 0.75
Cuprizone demyelination induces a unique inflammatory response in the subventricular zone. J Neuroinflammation (2016) 0.75
Di-(2-ethylhexyl) Phthalate-Induced Hippocampus-Derived Neural Stem Cells Proliferation. Cell J (2016) 0.75
Bone Morphogenetic Protein 4 Signalling in Neural Stem and Progenitor Cells during Development and after Injury. Stem Cells Int (2016) 0.75
Heterogeneous populations of neural stem cells contribute to myelin repair. Neural Regen Res (2017) 0.75
A novel SOX10 mutation in a patient with PCWH who developed hypoxic-ischemic encephalopathy after E. coli sepsis. Eur J Pediatr (2011) 0.75
Neuronal replacement from endogenous precursors in the adult brain after stroke. Nat Med (2002) 10.10
Long-distance neuronal migration in the adult mammalian brain. Science (1994) 8.02
Cellular composition and three-dimensional organization of the subventricular germinal zone in the adult mammalian brain. J Neurosci (1997) 6.74
Restricted proliferation and migration of postnatally generated neurons derived from the forebrain subventricular zone. Neuron (1993) 6.07
Unique astrocyte ribbon in adult human brain contains neural stem cells but lacks chain migration. Nature (2004) 5.85
Common developmental requirement for Olig function indicates a motor neuron/oligodendrocyte connection. Cell (2002) 5.64
The bHLH transcription factors OLIG2 and OLIG1 couple neuronal and glial subtype specification. Cell (2002) 5.35
Origin of oligodendrocytes in the subventricular zone of the adult brain. J Neurosci (2006) 4.90
In vitro neurogenesis by progenitor cells isolated from the adult human hippocampus. Nat Med (2000) 4.18
Autoradiographic and histological studies of postnatal neurogenesis. IV. Cell proliferation and migration in the anterior forebrain, with special reference to persisting neurogenesis in the olfactory bulb. J Comp Neurol (1969) 4.01
New neurons follow the flow of cerebrospinal fluid in the adult brain. Science (2006) 3.98
Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. N Engl J Med (2002) 3.68
Neuronal fate determinants of adult olfactory bulb neurogenesis. Nat Neurosci (2005) 3.67
Identification and isolation of multipotential neural progenitor cells from the subcortical white matter of the adult human brain. Nat Med (2003) 3.56
The Sox9 transcription factor determines glial fate choice in the developing spinal cord. Genes Dev (2003) 3.46
Adult ependymal cells are postmitotic and are derived from radial glial cells during embryogenesis. J Neurosci (2005) 3.19
From stem cells to neurons and glia: a Soxist's view of neural development. Trends Neurosci (2005) 3.07
Dopamine depletion impairs precursor cell proliferation in Parkinson disease. Nat Neurosci (2004) 2.84
Proliferation and differentiation of progenitor cells in the cortex and the subventricular zone in the adult rat after focal cerebral ischemia. Neuroscience (2001) 2.84
Progenitor cells of the adult mouse subventricular zone proliferate, migrate and differentiate into oligodendrocytes after demyelination. Eur J Neurosci (1999) 2.56
Cellular composition and cytoarchitecture of the adult human subventricular zone: a niche of neural stem cells. J Comp Neurol (2006) 2.53
Fetal and adult human oligodendrocyte progenitor cell isolates myelinate the congenitally dysmyelinated brain. Nat Med (2003) 2.46
Remyelination is extensive in a subset of multiple sclerosis patients. Brain (2006) 2.43
Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis. Brain Pathol (1996) 2.41
Chronic stage multiple sclerosis lesions contain a relatively quiescent population of oligodendrocyte precursor cells. J Neurosci (1998) 2.36
Increased cell proliferation and neurogenesis in the adult human Huntington's disease brain. Proc Natl Acad Sci U S A (2003) 2.36
Enhanced neurogenesis in Alzheimer's disease transgenic (PDGF-APPSw,Ind) mice. Proc Natl Acad Sci U S A (2004) 2.20
Oligodendrocyte progenitors are present in the normal adult human CNS and in the lesions of multiple sclerosis. Brain (1998) 2.16
Cell proliferation without neurogenesis in adult primate neocortex. Science (2001) 2.15
Multipotent stem/progenitor cells with similar properties arise from two neurogenic regions of adult human brain. Exp Neurol (1999) 2.14
Experimental autoimmune encephalomyelitis mobilizes neural progenitors from the subventricular zone to undergo oligodendrogenesis in adult mice. Proc Natl Acad Sci U S A (2002) 2.10
Neurogenesis in the subventricular zone and rostral migratory stream of the neonatal and adult primate forebrain. Exp Neurol (2001) 1.55
Prolonged seizures increase proliferating neuroblasts in the adult rat subventricular zone-olfactory bulb pathway. J Neurosci (2002) 1.46
Localization of epidermal growth factor receptors and putative neuroblasts in human subependymal zone. J Comp Neurol (2000) 1.40
Re-expression of PSA-NCAM by demyelinated axons: an inhibitor of remyelination in multiple sclerosis? Brain (2002) 1.33
Isolation of multipotent neural precursors residing in the cortex of the adult human brain. Exp Neurol (2001) 1.32
The fine structure of chronically active multiple sclerosis plaques. Neurology (1978) 1.30
Oligodendrocyte precursor cells in the demyelinated multiple sclerosis spinal cord. Brain (2002) 1.25
Axonal dystrophy as a consequence of long-term demyelination. Lab Invest (1989) 1.19
Endogenous adult neural stem cells: limits and potential to repair the injured central nervous system. J Neurosci Res (2004) 1.14
Increased number of neural progenitors in human temporal lobe epilepsy. Neurobiol Dis (2005) 1.12
Fibroblast growth factor-2 (FGF-2) and platelet-derived growth factor AB (PDGF AB) promote adult SVZ-derived oligodendrogenesis in vivo. Mol Cell Neurosci (2002) 1.06
Defective cell cycle control underlies abnormal cortical development in the hydrocephalic Texas rat. Brain (2003) 1.05
Characterization of the subventricular zone of the adult human brain: evidence for the involvement of Bcl-2. Neurosci Res (2000) 1.04
Increased proliferation of neural progenitor cells but reduced survival of newborn cells in the contralateral hippocampus after focal cerebral ischemia in rats. J Cereb Blood Flow Metab (2002) 1.02
Neuropathology in multiple sclerosis: new concepts. Mult Scler (1998) 0.99
Expression of the highly polysialylated neural cell adhesion molecule during postnatal myelination and following chemically induced demyelination of the adult mouse spinal cord. Eur J Neurosci (1995) 0.97
Remyelination in multiple sclerosis. Mult Scler (1997) 0.95
A proliferative adult human oligodendrocyte progenitor. Neuroreport (1995) 0.84
Loss of polysialic residues accelerates CNS neural precursor differentiation in pathological conditions. Mol Cell Neurosci (2002) 0.84
Bcl-2-expressing oligodendrocytes in multiple sclerosis lesions. Glia (1999) 0.81
Immune pathogenesis of multiple sclerosis. Brain autoimmune reactivity and its control by neuronal function. Mult Scler (1998) 0.77
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature (2011) 13.23
Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nat Genet (2010) 5.52
Inhibition of the mTORC pathway in the antiphospholipid syndrome. N Engl J Med (2014) 5.33
Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain (2007) 3.88
NG2-expressing glial progenitor cells: an abundant and widespread population of cycling cells in the adult rat CNS. Mol Cell Neurosci (2003) 3.69
Parkin prevents mitochondrial swelling and cytochrome c release in mitochondria-dependent cell death. Hum Mol Genet (2003) 3.51
Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease. J Clin Invest (2008) 2.91
Missing pieces in the Parkinson's disease puzzle. Nat Med (2010) 2.90
Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain. J Exp Med (2007) 2.88
Dopamine depletion impairs precursor cell proliferation in Parkinson disease. Nat Neurosci (2004) 2.84
CNS integrins switch growth factor signalling to promote target-dependent survival. Nat Cell Biol (2002) 2.38
Perforin-dependent brain-infiltrating cytotoxic CD8+ T lymphocytes mediate experimental cerebral malaria pathogenesis. J Immunol (2003) 2.22
Experimental autoimmune encephalomyelitis mobilizes neural progenitors from the subventricular zone to undergo oligodendrogenesis in adult mice. Proc Natl Acad Sci U S A (2002) 2.10
Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis. Brain (2011) 2.06
JNK-mediated induction of cyclooxygenase 2 is required for neurodegeneration in a mouse model of Parkinson's disease. Proc Natl Acad Sci U S A (2004) 2.05
Mixed-affinity binding in humans with 18-kDa translocator protein ligands. J Nucl Med (2010) 2.00
Critical role of IL-21 in modulating TH17 and regulatory T cells in Behçet disease. J Allergy Clin Immunol (2011) 1.94
Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's disease. Proc Natl Acad Sci U S A (2008) 1.93
Two binding sites for [3H]PBR28 in human brain: implications for TSPO PET imaging of neuroinflammation. J Cereb Blood Flow Metab (2010) 1.85
Staging of neurofibrillary pathology in Alzheimer's disease: a study of the BrainNet Europe Consortium. Brain Pathol (2008) 1.85
SOD1, ANG, VAPB, TARDBP, and FUS mutations in familial amyotrophic lateral sclerosis: genotype-phenotype correlations. J Med Genet (2010) 1.85
The pRb/E2F cell-cycle pathway mediates cell death in Parkinson's disease. Proc Natl Acad Sci U S A (2007) 1.78
A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis. Ann Neurol (2010) 1.69
NG2-expressing cells as oligodendrocyte progenitors in the normal and demyelinated adult central nervous system. J Anat (2005) 1.68
HDAC1 nuclear export induced by pathological conditions is essential for the onset of axonal damage. Nat Neurosci (2009) 1.67
Cholinergic mesencephalic neurons are involved in gait and postural disorders in Parkinson disease. J Clin Invest (2010) 1.64
Increased PK11195 PET binding in the cortex of patients with MS correlates with disability. Neurology (2012) 1.63
Related B cell clones populate the meninges and parenchyma of patients with multiple sclerosis. Brain (2011) 1.61
Mitochondrial DNA deletions and neurodegeneration in multiple sclerosis. Ann Neurol (2010) 1.60
Identification of Sox17 as a transcription factor that regulates oligodendrocyte development. J Neurosci (2006) 1.59
Myelin/oligodendrocyte glycoprotein-deficient (MOG-deficient) mice reveal lack of immune tolerance to MOG in wild-type mice. J Clin Invest (2003) 1.59
Interlaboratory comparison of assessments of Alzheimer disease-related lesions: a study of the BrainNet Europe Consortium. J Neuropathol Exp Neurol (2006) 1.56
A mutation of spastin is responsible for swellings and impairment of transport in a region of axon characterized by changes in microtubule composition. Hum Mol Genet (2006) 1.51
Management of a twenty-first century brain bank: experience in the BrainNet Europe consortium. Acta Neuropathol (2008) 1.51
Hyperkalaemia in a tetraplegic adolescent due to de novo sodium channel mutation. Nephrol Dial Transplant (2007) 1.50
Regulation of integrin growth factor interactions in oligodendrocytes by lipid raft microdomains. Curr Biol (2003) 1.43
Effects of antemortem and postmortem variables on human brain mRNA quality: a BrainNet Europe study. J Neuropathol Exp Neurol (2010) 1.36
Evidence of active microglia in substantia nigra pars compacta of parkinsonian monkeys 1 year after MPTP exposure. Glia (2004) 1.34
Re-expression of PSA-NCAM by demyelinated axons: an inhibitor of remyelination in multiple sclerosis? Brain (2002) 1.33
Substantial archaeocortical atrophy and neuronal loss in multiple sclerosis. Brain Pathol (2008) 1.32
Dysfunction of mitochondrial complex I and the proteasome: interactions between two biochemical deficits in a cellular model of Parkinson's disease. J Neurochem (2003) 1.32
Multiple roles for slits in the control of cell migration in the rostral migratory stream. J Neurosci (2004) 1.32
Dopamine and adult neurogenesis. J Neurochem (2006) 1.31
Molecular changes in normal appearing white matter in multiple sclerosis are characteristic of neuroprotective mechanisms against hypoxic insult. Brain Pathol (2003) 1.31
Thalamic neuronal activity in dopamine-depleted primates: evidence for a loss of functional segregation within basal ganglia circuits. J Neurosci (2005) 1.30
Consensus classification of human prion disease histotypes allows reliable identification of molecular subtypes: an inter-rater study among surveillance centres in Europe and USA. Acta Neuropathol (2012) 1.29
Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis. Brain (2012) 1.27
Behavioural disorders induced by external globus pallidus dysfunction in primates: I. Behavioural study. Brain (2004) 1.27
Assessment of beta-amyloid deposits in human brain: a study of the BrainNet Europe Consortium. Acta Neuropathol (2009) 1.27
The mitochondrial complex I inhibitor rotenone triggers a cerebral tauopathy. J Neurochem (2005) 1.27
Human blood-brain barrier disruption by retroviral-infected lymphocytes: role of myosin light chain kinase in endothelial tight-junction disorganization. J Immunol (2007) 1.26
Normal-appearing white matter in multiple sclerosis is in a subtle balance between inflammation and neuroprotection. Brain (2007) 1.24
Persistent increase in olfactory type G-protein alpha subunit levels may underlie D1 receptor functional hypersensitivity in Parkinson disease. J Neurosci (2004) 1.23
The role of SVZ-derived neural precursors in demyelinating diseases: from animal models to multiple sclerosis. J Neurol Sci (2007) 1.22
The phenotypic spectrum of progressive supranuclear palsy: a retrospective multicenter study of 100 definite cases. Mov Disord (2014) 1.20
Characterization of the striatal 6-OHDA model of Parkinson's disease in wild type and alpha-synuclein-deleted mice. Exp Neurol (2007) 1.20
Human endogenous retrovirus (HERV)-W ENV and GAG proteins: physiological expression in human brain and pathophysiological modulation in multiple sclerosis lesions. J Neurovirol (2005) 1.19
Cultured peripheral neuroglial cells are highly permissive to sheep prion infection. J Virol (2004) 1.19
Direct imaging of macrovascular and microvascular contributions to BOLD fMRI in layers IV-V of the rat whisker-barrel cortex. Neuroimage (2011) 1.19
Phenotype difference between ALS patients with expanded repeats in C9ORF72 and patients with mutations in other ALS-related genes. J Med Genet (2012) 1.19
Annonacin, a natural mitochondrial complex I inhibitor, causes tau pathology in cultured neurons. J Neurosci (2007) 1.18
Mixed brain pathologies in dementia: the BrainNet Europe consortium experience. Dement Geriatr Cogn Disord (2008) 1.17
Neuromelanin associated redox-active iron is increased in the substantia nigra of patients with Parkinson's disease. J Neurochem (2003) 1.16
Mutations in SQSTM1 encoding p62 in amyotrophic lateral sclerosis: genetics and neuropathology. Acta Neuropathol (2013) 1.16
C9ORF72 repeat expansions in the frontotemporal dementias spectrum of diseases: a flow-chart for genetic testing. J Alzheimers Dis (2013) 1.16
A phase 2 trial of the GSK-3 inhibitor tideglusib in progressive supranuclear palsy. Mov Disord (2014) 1.16
Epstein-Barr virus latent infection and BAFF expression in B cells in the multiple sclerosis brain: implications for viral persistence and intrathecal B-cell activation. J Neuropathol Exp Neurol (2010) 1.15
Evidence of left inferior frontal-premotor structural and functional connectivity deficits in adults who stutter. Cereb Cortex (2011) 1.15
Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats. J Neurochem (2003) 1.15
Endogenous adult neural stem cells: limits and potential to repair the injured central nervous system. J Neurosci Res (2004) 1.14
A new model to study compensatory mechanisms in MPTP-treated monkeys exhibiting recovery. Brain (2007) 1.14
Expression and function of junctional adhesion molecule-C in myelinated peripheral nerves. Science (2007) 1.14
In vivo transcranial brain surgery with an ultrasonic time reversal mirror. J Neurosurg (2007) 1.13
Lack of up-regulation of ferritin is associated with sustained iron regulatory protein-1 binding activity in the substantia nigra of patients with Parkinson's disease. J Neurochem (2002) 1.13
New striatal dopamine neurons in MPTP-treated macaques result from a phenotypic shift and not neurogenesis. Brain (2006) 1.12
A stable proportion of Lewy body bearing neurons in the substantia nigra suggests a model in which the Lewy body causes neuronal death. Neurobiol Aging (2008) 1.11
Rational therapeutic approaches to progressive supranuclear palsy. Brain (2010) 1.11
Nogo expression in muscle correlates with amyotrophic lateral sclerosis severity. Ann Neurol (2005) 1.11
Rescue of mesencephalic dopaminergic neurons in culture by low-level stimulation of voltage-gated sodium channels. J Neurosci (2004) 1.10
Grafts of brain-derived neurotrophic factor and neurotrophin 3-transduced primate Schwann cells lead to functional recovery of the demyelinated mouse spinal cord. J Neurosci (2005) 1.09
Protection of midbrain dopaminergic neurons by the end-product of purine metabolism uric acid: potentiation by low-level depolarization. J Neurochem (2009) 1.09
Rapid detection of adenovirus in throat swab specimens by PCR during respiratory disease outbreaks among military recruits. J Clin Microbiol (2003) 1.09
Assessment of alpha-synuclein pathology: a study of the BrainNet Europe Consortium. J Neuropathol Exp Neurol (2008) 1.08
TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions. Acta Neuropathol (2014) 1.08
Annonacin, a lipophilic inhibitor of mitochondrial complex I, induces nigral and striatal neurodegeneration in rats: possible relevance for atypical parkinsonism in Guadeloupe. J Neurochem (2004) 1.08
Notch, epidermal growth factor receptor, and beta1-integrin pathways are coordinated in neural stem cells. J Biol Chem (2005) 1.07
Microglial glucocorticoid receptors play a pivotal role in regulating dopaminergic neurodegeneration in parkinsonism. Proc Natl Acad Sci U S A (2011) 1.07
Fibroblast growth factor-2 (FGF-2) and platelet-derived growth factor AB (PDGF AB) promote adult SVZ-derived oligodendrogenesis in vivo. Mol Cell Neurosci (2002) 1.06
Inflammation and dopaminergic neuronal loss in Parkinson's disease: a complex matter. Exp Neurol (2003) 1.06
Axon loss is responsible for chronic neurological deficit following inflammatory demyelination in the rat. Exp Neurol (2005) 1.06
Behavioral changes are not directly related to striatal monoamine levels, number of nigral neurons, or dose of parkinsonian toxin MPTP in mice. Neurobiol Dis (2003) 1.05
Normal and pathological gait: what we learn from Parkinson's disease. J Neurol Neurosurg Psychiatry (2012) 1.04
Dopaminergic substantia nigra neurons project topographically organized to the subventricular zone and stimulate precursor cell proliferation in aged primates. J Neurosci (2006) 1.04